221 related articles for article (PubMed ID: 8105616)
1. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
Fogh K; Iversen L; Herlin T; Kragballe K
Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
[TBL] [Abstract][Full Text] [Related]
2. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
Fogh K; Herlin T; Kragballe K
J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
Fogh K; Herlin T; Kragballe K
Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922
[TBL] [Abstract][Full Text] [Related]
4. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
Kragballe K; Duell EA; Voorhees JJ
Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
[TBL] [Abstract][Full Text] [Related]
5. Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199.
Schnyder J; Hunziker T; Strasser M; Richardson B; Krebs A
Arch Dermatol Res; 1986; 278(6):494-6. PubMed ID: 3024587
[No Abstract] [Full Text] [Related]
6. In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
Kragballe K; Desjarlais L; Duell EA; Voorhees JJ
J Invest Dermatol; 1986 Jul; 87(1):47-52. PubMed ID: 3088130
[TBL] [Abstract][Full Text] [Related]
7. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.
Fogh K; Herlin T; Kragballe K
J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):450-5. PubMed ID: 2537352
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
[TBL] [Abstract][Full Text] [Related]
9. Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin.
Duell EA; Ellis CN; Voorhees JJ
J Invest Dermatol; 1988 Nov; 91(5):446-50. PubMed ID: 2844912
[TBL] [Abstract][Full Text] [Related]
10. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
[TBL] [Abstract][Full Text] [Related]
11. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
[TBL] [Abstract][Full Text] [Related]
13. Eicosanoid production by human aortic endothelial cells in response to endothelin.
Hollenberg SM; Tong W; Shelhamer JH; Lawrence M; Cunnion RE
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2290-6. PubMed ID: 7810729
[TBL] [Abstract][Full Text] [Related]
14. 15-HETE is the main eicosanoid formed by human colonic mucosa.
Zijlstra FJ; van Dijk AP; Wilson JH; van Riemsdijk-Overbeeke IC; Vincent JE; Ouwendijk RJ
Agents Actions; 1992; Spec No():C53-9. PubMed ID: 1442336
[TBL] [Abstract][Full Text] [Related]
15. Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis.
Solá J; Godessart N; Vila L; Puig L; de Moragas JM
J Invest Dermatol; 1992 Mar; 98(3):333-9. PubMed ID: 1312107
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eicosanoid formation in human polymorphonuclear leukocytes by high concentrations of magnesium ions.
Ludwig P; Petrich K; Schewe T; Diezel W
Biol Chem Hoppe Seyler; 1995 Dec; 376(12):739-44. PubMed ID: 9072050
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid metabolism by rat alveolar epithelial cells.
Chauncey JB; Peters-Golden M; Simon RH
Lab Invest; 1988 Feb; 58(2):133-40. PubMed ID: 2828765
[TBL] [Abstract][Full Text] [Related]
18. Monitoring eicosanoid biosynthesis via lipoxygenase and cyclooxygenase pathways in human whole blood by single HPLC run.
Frohberg P; Drutkowski G; Wobst I
J Pharm Biomed Anal; 2006 Jun; 41(4):1317-24. PubMed ID: 16621414
[TBL] [Abstract][Full Text] [Related]
19. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.
He C; Wu Y; Lai Y; Cai Z; Liu Y; Lai L
Mol Biosyst; 2012 Apr; 8(5):1585-94. PubMed ID: 22446875
[TBL] [Abstract][Full Text] [Related]
20. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway.
Iversen L; Fogh K; Kragballe K
Arch Dermatol Res; 1992; 284(4):222-6. PubMed ID: 1329675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
